- Home
- BODI vs CVKD Comparison
BODI vs CVKD Comparison
Compare BODI & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BODI
- CVKD
- Stock Information
- Founded
- BODI 1998
- CVKD 2022
- Country
- BODI United States
- CVKD United States
- Employees
- BODI N/A
- CVKD N/A
- Industry
- BODI Industrial Machinery/Components
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- BODI Industrials
- CVKD Health Care
- Exchange
- BODI Nasdaq
- CVKD Nasdaq
- Market Cap
- BODI 25.4M
- CVKD 29.5M
- IPO Year
- BODI N/A
- CVKD 2023
- Fundamental
- Price
- BODI $4.06
- CVKD $11.17
- Analyst Decision
- BODI Strong Buy
- CVKD Strong Buy
- Analyst Count
- BODI 3
- CVKD 1
- Target Price
- BODI $10.67
- CVKD $32.00
- AVG Volume (30 Days)
- BODI 18.9K
- CVKD 35.1K
- Earning Date
- BODI 08-05-2025
- CVKD 08-06-2025
- Dividend Yield
- BODI N/A
- CVKD N/A
- EPS Growth
- BODI N/A
- CVKD N/A
- EPS
- BODI N/A
- CVKD N/A
- Revenue
- BODI $371,113,000.00
- CVKD N/A
- Revenue This Year
- BODI N/A
- CVKD N/A
- Revenue Next Year
- BODI N/A
- CVKD N/A
- P/E Ratio
- BODI N/A
- CVKD N/A
- Revenue Growth
- BODI N/A
- CVKD N/A
- 52 Week Low
- BODI $3.38
- CVKD $5.70
- 52 Week High
- BODI $8.71
- CVKD $22.90
- Technical
- Relative Strength Index (RSI)
- BODI 51.85
- CVKD 36.41
- Support Level
- BODI $3.81
- CVKD $12.27
- Resistance Level
- BODI $4.15
- CVKD $13.63
- Average True Range (ATR)
- BODI 0.28
- CVKD 1.02
- MACD
- BODI 0.02
- CVKD 0.07
- Stochastic Oscillator
- BODI 53.75
- CVKD 31.21
About BODI The Beachbody Company Inc. Class A Common Stock
The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in one operating segment. Majority of revenue is through Digital.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.